02 dec: Vinskolen lektion 2: Kend dine klassikere - De tre store
03 dec: Udligningsskat fra 1.januar 2011
03-12-2010 08:39:53

Royal Unibrew and Van Pur team up in Poland

Relateret indhold
12 dec - 
Tirsdagens aktier: Genmab og Vestas holdt C20 i kort sn..
12 dec - 
Aktier/middag: Genmab ryger ned på usikkerhed om 2018-f..
27 nov - 
Unibrew/Jyske: Kursmålet løftes med en tyver - gentager..
Relateret debat
12 dec - 
I en tid hvor experterne står i kø for at nedgradere Rb..
12 dec - 
Hm ser ud til, at min egen opfattelse var i den 'rigtig..
12 dec - 
Garnier - er det ikke noget med shampoo?

Company Announcement No 26/2010

3 December 2010

Royal Unibrew A/S has entered into a conditional agreement with the Polish

brewery group Van Pur SA partly to merge Van Pur SA and Royal Unibrew Polska

Sp. z o.o with the breweries in Lomza and in Jedrzejow, and partly to transfer

Royal Unibrew's share of the brewery Browary Lubelskie ”Perla” SA. Van Pur SA

will be the future company, with Royal Unibrew A/S as a 20% shareholder.

Provided the transaction is completed, the medium-term target for Royal Unibrew

A/S's EBIT margin will be increased from around 13% to around 14%.

Van Pur SA is a medium-sized, Polish brewery business with strong profitability

which operates three breweries in Poland. The Company's key brands include

Karpackie which is successfully marketed in the mainstream segment. Van Pur's

share of the Polish beer market is approx. 4.3%.

Following the intended merger with Royal Unibrew Polska, Van Pur SA will be the

number four brewery in Poland in terms of size with a market share of approx.

7%, substantial exports and total annual volumes of approx. 3.3 million

hectolitres. Based on the outlook for 2010 and with Royal Unibrew Polska Sp. z

o.o as a wholly-owned subsidiary, the future Van Pur SA will have pro forma net

revenue of approx. DKK 1 billion.

Ms Beata Pawlowska, the current Managing Director of Royal Unibrew Polska Sp. z

o.o., is expected to be assigned responsibility for the merged activities.

According to Royal Unibrew's previously announced strategy, Royal Unibrew A/S

has an objective of having or achieving a considerable position in the main

segments in the markets in which the Company operates. With the intended merger

with Van Pur SA, Royal Unibrew A/S has taken a major step towards achieving

such a position in Poland.

In connection with the agreement, Royal Unibrew A/S has granted Van Pur SA and

its shareholders a call option, according to which Van Pur and its shareholders

in the period from 1 June 2012 through 15 March 2014 may acquire all Van Pur SA

shares held by Royal Unibrew at an amount between PLN 116 million and PLN 121

million.

The parties have entered into a shareholders' agreement securing Royal Unibrew

A/S protection as a minority shareholder.

The agreement, which is conditional upon, among other things, approval by the

Polish competition authorities, is expected to be finally completed at the end

of Q1 2011.

Following completion of the transaction, the Polish activities will no longer

be included in the Royal Unibrew A/S Group consolidation; however, the Van Pur

SA shareholding will be recognised as an associate in the Financial Statements.

The realised value of Royal Unibrew A/S's Polish activities upon the merger

with Van Pur SA is - depending on any adjustments in connection with the final

realisation of the transaction - expected to be at the level of their book

value (approx. PLN 100 million).

Royal Unibrew Polska is expected to achieve revenue of approx. DKK 360 million

and EBITDA at the level of DKK 20 million for 2010. The transaction is not

expected to affect Royal Unibrew A/S's outlook for 2010.

Royal Unibrew's outlook for 2011, which will be announced on 9 March 2011, will

take into account this conditional transaction. The expected timing of the

approval by the Polish competition authorities implies that the usually

unprofitable Q1 of Royal Unibrew Polska will be included in the Consolidated

Financial Statements of Royal Unibrew in 2011.

Assuming that the transaction is completed, the medium-term EBIT margin target

will be upgraded to around 14% compared to the around 13% announced on 25

November 2010 in connection with the presentation of the Interim Report for 1

January - 30 September 2010.

Yours sincerely

Royal Unibrew A/S

Henrik Brandt

President and CEO

Please direct any questions to me at tel +45 56 77 15 13.

Vedhæftet fil 1: Vedhæftet fil 1
Vedhæftet fil 2: Vedhæftet fil 2

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
12 dec
RBREW
Fra BG: Royal Unibrew is a very efficient and nimble operator which has managed to improve its margi..
2
12 dec
RBREW
Fra Handelsbanken:   Royal Unibrew-aktien har i år været et godt bekendtskab, hvor aktien er steget ..
1
12 dec
RBREW
Bryan Garnier sænker Unibrew til Sell fra Neutral i en ny analyse fra i dag. Handelsbanken har også ..
1

Fondsbørsmeddelelser

Novo-rival spår effekt af ugentligt GLP-1 på linje med Ozempics

13-12-2017 13:30:09
Novo Nordisks store franske rival Sanofi forudser, at dens ugentlige GLP-1-analog, Efpeglenatid, har en effekt på langtidsblodsukkeret, der er på linje Novos nye ugentlige diabetes 2-middel Ozempic, som tilhører samme lægemiddelklasse.Det fremgår af en præsentation under et analytikerarrangement onsdag, hvor Sanofi fremlægger sin forsknings- og udviklingsstrategi for de kommende år.Sanofi indledte..

Novo-rival er på vej med nye studier i fedme og leversygdommen NASH

13-12-2017 09:56:25
Novo Nordisks store franske rival, Sanofi, vil ligesom Novo i de kommende år også fokusere på udviklingen af fedmemedicin og medicin til behandling af leversygdommen, NASH.Det fremgår af en pressemeddelelse i forbindelse med et analytikerarrangement onsdag, hvor Sanofi vil præsentere sin forsknings- og udviklingsstrategi for de kommende år.Sanofis udviklingsindsats inden for forretningsområdet, di..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas får sin største ordre nogensinde i Indien - NY
2
Vestas rykker nærmere kæmpekontrakter i New Mexico og Texas
3
Aktier/tendens: Genmab og Vestas fortsætter i fokus
4
Vestas ejer mere end 5 pct. egne aktier efter opkøb
5
Onsdagens aktier: Genmab endnu engang til bunds i negativt marked

Relaterede aktiekurser

Royal Unibrew A/S 360,30 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
14. december 2017 03:31:06
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171124.1 - EUROWEB4 - 2017-12-14 03:31:06 - 2017-12-14 03:31:06 - 1 - Website: OKAY